BioXcel Therapeutics, Inc. (BTAIQ)
0.052
+0.01
(+15.56%)
USD |
OTCM |
Oct 02, 16:00
BioXcel Therapeutics EPS Diluted (Quarterly) : -0.4856 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.4856 |
| March 31, 2026 | -0.5384 |
| December 31, 2025 | -1.028 |
| September 30, 2025 | -2.177 |
| June 30, 2025 | -2.446 |
| March 31, 2025 | -1.501 |
| December 31, 2024 | -3.573 |
| September 30, 2024 | -0.322 |
| June 30, 2024 | -0.2062 |
| March 31, 2024 | -0.8679 |
| December 31, 2023 | -0.7558 |
| September 30, 2023 | -1.725 |
| June 30, 2023 | -1.834 |
| March 31, 2023 | -1.845 |
| December 31, 2022 | -1.953 |
| September 30, 2022 | -1.492 |
| June 30, 2022 | -1.346 |
| March 31, 2022 | -1.125 |
| December 31, 2021 | -0.9337 |
| Date | Value |
|---|---|
| September 30, 2021 | -0.9585 |
| June 30, 2021 | -1.106 |
| March 31, 2021 | -1.076 |
| December 31, 2020 | -0.8651 |
| September 30, 2020 | -1.074 |
| June 30, 2020 | -1.056 |
| March 31, 2020 | -0.7861 |
| December 31, 2019 | -0.4575 |
| September 30, 2019 | -0.5725 |
| June 30, 2019 | -0.5406 |
| March 31, 2019 | -0.4599 |
| December 31, 2018 | -0.4517 |
| September 30, 2018 | -0.3124 |
| June 30, 2018 | -0.19 |
| March 31, 2018 | -0.37 |
| December 31, 2017 | -2.457 |
| September 30, 2017 | -0.0557 |
| December 31, 2016 | -0.5451 |
| September 30, 2016 | -0.0329 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | -0.0146 |
| Amgen, Inc. | 4.366 |
| BioCryst Pharmaceuticals, Inc. | 0.2957 |
| Imunon, Inc. | -0.5412 |
| Curis, Inc. | -4.017 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -14.71M |
| Revenue (Quarterly) | 0.182M |
| Total Expenses (Quarterly) | 14.90M |
| Enterprise Value | 92.28M |
| Gross Profit Margin (Quarterly) | 78.02% |
| Profit Margin (Quarterly) | -8.08K% |
| Earnings Yield | -8.13K% |
| Normalized Earnings Yield | -7054.04 |